Janus Henderson Group PLC Arca Biopharma, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Arca Biopharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,382,736 shares of ABIO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,382,736Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABIO
# of Institutions
37Shares Held
13MCall Options Held
41.6KPut Options Held
5.6K-
Cable Car Capital LLC San Francisco, CA4MShares$016.14% of portfolio
-
Rtw Investments, LP New York, NY1.4MShares$00.09% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.2MShares$00.01% of portfolio
-
Avidity Partners Management LP Dallas, TX1MShares$00.19% of portfolio
-
Vr Adviser, LLC New York, NY866KShares$00.36% of portfolio
About ARCA biopharma, Inc.
- Ticker ABIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,410,100
- Description
- ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...